Page 39 - TD-1-1
P. 39

Tumor Discovery                                              The mechanism of cancer-related cognitive decline



               Neurocognitive decline following radiotherapy: Mechanisms   https://doi.org/10.1007/s00018-019-03428-3
               and therapeutic implications. Cancers (Basel), 12: 146.
                                                               84. Lanni C, Masi M, Racchi M, et  al., 2021, Cancer and
               https://doi.org/10.3390/cancers12010146            Alzheimer’s disease inverse relationship: an age-associated
            79. McDowell LJ, Ringash J, Xu W, et al., 2019, A cross sectional   diverging derailment of shared pathways. Mol  Psychiatry,
               study in cognitive and neurobehavioral impairment in long-  26(1): 280–295.
               term nasopharyngeal cancer survivors treated with intensity-  https://doi.org/10.1038/s41380-020-0760-2
               modulated radiotherapy. Radiother Oncol, 131: 179–185.
                                                               85. Nebbioso A, Tambaro FP, Dell’Aversana C, et  al., 2018,
               https://doi.org/10.1016/j.radonc.2018.09.012
                                                                  Cancer epigenetics: moving forward. PLoS Genet, 14(6):
            80. Haldbo-Classen L, Amidi A, Lukacova S,  et al., 2020,  e1007362.
               Cognitive impairment following radiation to hippocampus  https://doi.org/10.1371/journal.pgen.1007362
               and other brain structures in adults with primary brain
               tumours. Radiother Oncol, 148: 1–7.             86. Rebeck GW, 2017, The role of APOE on lipid homeostasis
               https://doi.org/10.1016/j.radonc.2020.03.023       and inflammation in normal brains. J  Lipid  Res, 58(8):
                                                                  1493–1499.
            81. Makale  MT, McDonald CR, Hattangadi-Gluth JA,  et al.,
               2017, Mechanisms of radiotherapy-associated cognitive  https://doi.org/10.1194/jlr.R075408
               disability in patients with brain tumours. Nat Rev Neurol,  87. Ahles TA, Saykin AJ, Noll WW, et al., 2003, The
               13(1): 52–64.                                      relationship of APOE genotype to neuropsychological
               https://doi.org/10.1038/nrneurol.2016.185          performance  in long-term cancer survivors treated with
            82. McHugh D, Gil J, 2018, Senescence and aging: causes,  standard dose  chemotherapy. Psychooncology, 12(6): 612–
               consequences, and therapeutic avenues. J Cell Biol, 217(1):  619.
               65–77.                                             https://doi.org/10.1002/pon.742
               https://doi.org/10.1083/jcb.201708092           88. Fernandez HR, Varma A, Flowers SA, et  al., 2020, Cancer
            83. Seo J, Park M, 2020, Molecular crosstalk between cancer  chemotherapy related cognitive impairment and the impact
               and neurodegenerative diseases.  Cell Mol Life Sci, 77(14):  of the Alzheimer’s disease risk factor APOE. Cancers (Basel),
               2659–2680.                                         12: 3842.
                                                                  https://doi.org/10.3390/cancers12123842







































            Volume 1 Issue 1 (2022)                         11                       https://doi.org/10.36922/td.v1i1.46
   34   35   36   37   38   39   40   41   42   43   44